首页> 美国卫生研究院文献>Turkish Journal of Ophthalmology >Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study Bosphorus Retina Study Group Report No: 1

【2h】

Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study Bosphorus Retina Study Group Report No: 1

机译：土耳其新血管性年龄相关性黄斑变性的抗VEGF治疗的实际结果：多中心回顾性研究博斯普鲁斯海峡视网膜研究组报告第1号

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives:To evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in neovascular age-related macular degeneration (nAMD) patients.

机译：目的：评估玻璃体腔内抗血管内皮生长因子（anti-VEGF）治疗新血管性年龄相关性黄斑变性（nAMD）患者的真实结果。

著录项

期刊名称 Turkish Journal of Ophthalmology
作者
Abdullah Özkaya; Levent Karabaş; Cengiz Alagöz; Zeynep Alkın; Özgür Artunay; Selim Bölükbaşı; Gökhan Demir; Mehmet Demir; Ali Demircan; Burak Erden; Gürkan Erdoğan; Mehmet Erdoğan; Erdem Eriş; Havva Kaldırım; İsmail Umut Onur; Özen Osmanbaşoğlu; Sezin Özdoğan Erkul; Mine Öztürk; İrfan Perente; Kübra Sarıcı; Nihat Sayın; Dilek Yaşa; İhsan Yılmaz; Zeynep Yılmazabdurrahmanoğlu;
展开▼
作者单位

展开▼
年(卷),期 2018(48),5
年度 2018
页码 232–237
总页数 6
原文格式 PDF
正文语种
中图分类眼科学;
关键词
Age-related macular degeneration anti-vascular endothelial growth factor treatment;

机译：年龄相关性黄斑变性;抗血管内皮生长因子;治疗;

相似文献

外文文献
中文文献
专利

1. Comparison of two different treatment regimens'''' efficacy in neovascular age-related macular degeneration in Turkish population—based on real life data-Bosphorus RWE Study Group [J] . Burak Erden, Selim Bölükbaşı, AbdullahÖzkaya, 国际眼科杂志：英文版 . 2020,第001期

机译：基于现实生活数据的两种不同治疗方案在土耳其人群中与新生血管性年龄相关性黄斑变性的疗效比较-博斯普鲁斯海峡RWE研究组
2. Pilot study to evaLuate the role of high-dose rAnibizumab 2.0 mg in the management of neovascular age-related macular degeneration in patients with perSistent/recurrenT macular fluid <30 days following treatment with intravitreal anti-VEGF therapy (the LAST Study) [J] . FungA.T., KumarN., VanceS.K., Eye . 2012,第9期

机译：在玻璃体内注射抗VEGF治疗后持续/复发性黄斑积液<30天的患者中评估大剂量rAnibizumab 2.0 mg在管理新生血管性年龄相关性黄斑变性中的作用的试验研究（LAST研究）
3. Treatment of neovascular age-related macular degeneration with anti-VEGF agents: retrospective analysis of 5-year outcomes [J] . Ana Catarina Pedrosa, Adriana Reis-Silva, Jo?o Pinheiro-Costa, Clinical ophthalmology . 2016,第6期

机译：抗血管内皮生长因子药物治疗新生血管性年龄相关性黄斑变性：5年预后的回顾性分析
4. Bevacizumab (Avastin) conjugated microbubbles for anti-VEGF treatment of neovascular age-related macular degeneration [C] . Leilei Zhang, Jeff Xu, Jiwei Huang, Conference on ophthalmic technologies . 2010

机译：贝伐单抗（Avastin）缀合的微泡用于抗VEGF治疗新生血管性年龄相关性黄斑变性
5. Functional independence and life satisfaction with vision loss from age-related macular degeneration: A study of older adults. [D] . Elfervig, Lucie Theresa Savoie. 1996

机译：与年龄相关的黄斑变性所致视力丧失的功能独立性和生活满意度：对老年人的研究。
6. Comparison of two different treatment regimens efficacy in neovascular age-related macular degeneration in Turkish population—based on real life data-Bosphorus RWE Study Group [O] . Burak Erden, Selim Bölükbaşı, Abdullah Özkaya, 2020

机译：基于真实生活数据的两种不同治疗方案对土耳其人群新血管性年龄相关性黄斑变性的疗效比较-基于真实生活数据-Bosphorus RWE研究组
7. Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1 [O] . Abdullah Özkaya, Levent Karabaş, Cengiz Alagöz, 2018

机译：土耳其新生血管年龄相关性黄斑变性的现实世界抗VEGF治疗结果：多中心回顾性研究，Bosphorus Retina研究组报告说明：1

Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study Bosphorus Retina Study Group Report No: 1

摘要

著录项

相似文献

相关主题

期刊订阅